Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults, according to new UCLA-led research.

He also worked on The Journal’s publishing desk; as a writer and editor covering stocks at Barron’s; as an editor of features at MarketWatch; and on product development efforts at The Journal.  ...

Concerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday.

Still, Mafi says there aren't strong data on how Paxlovid affects the disease course in people who are vaccinated. His findings suggest that the benefits are about four times smaller than those ...

Albumin Market Trends 2025 Significant surge in non-therapeutic application of albumin, increasing production of immunoglobulins & plasma c ...

Covid hospitalizations were not significantly reduced when adults used the antiviral pill, researchers find. Also, a nationwide study suggests estrogen may play a role in long covid, putting women at ...

Influenza is surging in Canada, with a test positivity rate of 24.3% in the first week of February, according to data from ...

If you had any doubt about the “vibe shift” in 2025 Washington, look no further than the impact the Make America Healthy ...

An outbreak of measles is wreaking havoc in the South Plains region of Texas, where nearly 60 children have been confirmed to ...